Program will make costly melanoma drug therapy available in Ontario

In the same week that Russell’s Carolyn Pol died from advanced melanoma, her family learned a promising combination of immunotherapy drugs will now be covered for other Ontario patients.
Pol and her family were forced to raise tens of thousands of dollars for the drugs last summer. At the time, the drug combination was not covered by the Ontario government — even though the drugs, ipilimumab (Yervoy) and nivolumab (Opdivo), were publicly funded when used on their own.
Fundraising and